Synergistic effect of cold gas plasma and experimental drug exposure exhibits skin cancer toxicity in vitro and in vivo
暂无分享,去创建一个
B. Nebe | M. Hein | T. von Woedtke | R. Ramer | B. Hinz | B. Vollmar | H. Rebl | L. Miebach | Sander Bekeschus | H. Metelmann | C. Seebauer | E. Grambow | L. Boeckmann | M. Schäfer | M. Semmler | Marie Sawade | Peter Langer | M. Kordt | Felix Niessner | J. Berner | S. Emmert | P. Langer | Anna Frey | S. Sagwal | Elea Lenz
[1] Ramona Clemen,et al. Argon Humidification Exacerbates Antimicrobial and Anti-MRSA kINPen Plasma Activity , 2023, Life.
[2] Yitian Jiang,et al. Emerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy , 2022, Advanced science.
[3] J. Pourahmad,et al. Cold Atmospheric Plasma Versus Cisplatin Against Oral Squamous Cell Carcinoma: A Mitochondrial Targeting Study , 2022, Iranian journal of pharmaceutical research : IJPR.
[4] M. Keidar,et al. Theranostic Potential of Adaptive Cold Atmospheric Plasma with Temozolomide to Checkmate Glioblastoma: An In Vitro Study , 2022, Cancers.
[5] M. Keidar,et al. Cold Plasma Discharge Tube Enhances Anti-Tumoral Efficacy of Temozolomide , 2022, 2022 IEEE International Conference on Plasma Science (ICOPS).
[6] M. Jung,et al. Plasma-activated medium inhibits cancer stem cell-like properties and exhibits a synergistic effect in combination with cisplatin in ovarian cancer. , 2022, Free radical biology & medicine.
[7] Dean P. Jones,et al. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology , 2022, Nature Reviews Molecular Cell Biology.
[8] T. von Woedtke,et al. Conductivity augments ROS and RNS delivery and tumor toxicity of an argon plasma jet. , 2022, Free radical biology & medicine.
[9] M. Stope,et al. H2A.X Phosphorylation in Oxidative Stress and Risk Assessment in Plasma Medicine , 2021, Oxidative medicine and cellular longevity.
[10] S. Bekeschus,et al. ROS Pleiotropy in Melanoma and Local Therapy with Physical Modalities , 2021, Oxidative medicine and cellular longevity.
[11] N. Masand,et al. Chromones: Privileged scaffold in anticancer drug discovery , 2021, Chemical biology & drug design.
[12] M. Keidar,et al. In Vitro and In Vivo Enhancement of Temozolomide Effect in Human Glioblastoma by Non-Invasive Application of Cold Atmospheric Plasma , 2021, Cancers.
[13] T. von Woedtke,et al. Medical gas plasma-stimulated wound healing: Evidence and mechanisms , 2021, Redox biology.
[14] M. Keidar,et al. Low-Temperature Plasma for Biology, Hygiene, and Medicine: Perspective and Roadmap , 2021, IEEE Transactions on Radiation and Plasma Medical Sciences.
[15] S. Antimisiaris,et al. Synergistic effect of cold atmospheric pressure plasma and free or liposomal doxorubicin on melanoma cells , 2021, Scientific Reports.
[16] L. Zhong,et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives , 2021, Signal Transduction and Targeted Therapy.
[17] M. Shakibaei,et al. Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles , 2021, EPMA Journal.
[18] K. Song,et al. Selective Anti-Cancer Effects of Plasma-Activated Medium and Its High Efficacy with Cisplatin on Hepatocellular Carcinoma with Cancer Stem Cell Characteristics , 2021, International journal of molecular sciences.
[19] Naresh Kumar,et al. Cold Atmospheric Plasma Increases Temozolomide Sensitivity of Three-Dimensional Glioblastoma Spheroids via Oxidative Stress-Mediated DNA Damage , 2021, Cancers.
[20] Y. Fujisawa,et al. Five‐year survival with nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma , 2021, The Journal of dermatology.
[21] M. Lalk,et al. Gas Plasma Technology Augments Ovalbumin Immunogenicity and OT‐II T Cell Activation Conferring Tumor Protection in Mice , 2021, Advanced science.
[22] F. Jiang,et al. Recent Advances in Nanomaterial‐Based Nanoplatforms for Chemodynamic Cancer Therapy , 2021, Advanced Functional Materials.
[23] R. Ramer,et al. The Monoacylglycerol Lipase Inhibitor JZL184 Inhibits Lung Cancer Cell Invasion and Metastasis via the CB1 Cannabinoid Receptor , 2021, Molecular Cancer Therapeutics.
[24] Dingxin Liu,et al. Study of the anticancer effects of a helium plasma jet combined with four anticancer drugs on 3D bladder tumour spheroids , 2021 .
[25] A. Bogaerts,et al. Physical Plasma-Treated Skin Cancer Cells Amplify Tumor Cytotoxicity of Human Natural Killer (NK) Cells , 2020, Cancers.
[26] M. Keidar,et al. Sensitization of glioblastoma cells to temozolomide by a helium gas discharge tube , 2020 .
[27] T. von Woedtke,et al. Risk Evaluation of EMT and Inflammation in Metastatic Pancreatic Cancer Cells Following Plasma Treatment , 2020, Frontiers in Physics.
[28] M. Keidar,et al. Combination therapy of cold atmospheric plasma (CAP) with temozolomide in the treatment of U87MG glioblastoma cells , 2020, Scientific Reports.
[29] M. Santoro,et al. Adaptive redox homeostasis in cutaneous melanoma , 2020, Redox biology.
[30] Chang-Min Lee,et al. Combinatorial Effect of Cold Atmosphere Plasma (CAP) and the Anticancer Drug Cisplatin on Oral Squamous Cell Cancer Therapy , 2020, International journal of molecular sciences.
[31] B. Nebe,et al. Cold Atmospheric Pressure Plasma in Wound Healing and Cancer Treatment , 2020, Applied Sciences.
[32] M. Scarpa,et al. Reactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion , 2020, Cancers.
[33] T. von Woedtke,et al. Plasma Treatment Limits Cutaneous Squamous Cell Carcinoma Development In Vitro and In Vivo , 2020, Cancers.
[34] G. Davison,et al. A combined γ-H2AX and 53BP1 approach to determine the DNA damage-repair response to exercise in hypoxia. , 2020, Free radical biology & medicine.
[35] Sander Bekeschus,et al. Medical Gas Plasma Jet Technology Targets Murine Melanoma in an Immunogenic Fashion , 2020, Advanced science.
[36] K. Weltmann,et al. Plasma medical oncology: Immunological interpretation of head and neck squamous cell carcinoma , 2020 .
[37] J. Lafontaine,et al. Synergy between Non-Thermal Plasma with Radiation Therapy and Olaparib in a Panel of Breast Cancer Cell Lines , 2020, Cancers.
[38] Michael R Hamblin,et al. Photodynamic Therapy for Cancer: What's Past is Prologue , 2019, Photochemistry and photobiology.
[39] B. Nebe,et al. Pyruvate as a cell‐protective agent during cold atmospheric plasma treatment in vitro: Impact on basic research for selective killing of tumor cells , 2019, Plasma Processes and Polymers.
[40] E. Choi,et al. Cold Atmospheric Plasma Restores Paclitaxel Sensitivity to Paclitaxel-Resistant Breast Cancer Cells by Reversing Expression of Resistance-Related Genes , 2019, Cancers.
[41] T. von Woedtke,et al. Elevated H2AX Phosphorylation Observed with kINPen Plasma Treatment Is Not Caused by ROS-Mediated DNA Damage but Is the Consequence of Apoptosis , 2019, Oxidative medicine and cellular longevity.
[42] A. Tjønneland,et al. Flavonoid intake is associated with lower mortality in the Danish Diet Cancer and Health Cohort , 2019, Nature Communications.
[43] P. Terheyden,et al. The Systemic Treatment of Melanoma. , 2019, Deutsches Arzteblatt international.
[44] Wei Zhang,et al. The antitumor activity of naturally occurring chromones: A review. , 2019, Fitoterapia.
[45] Sander Bekeschus,et al. Combination of chemotherapy and physical plasma elicits melanoma cell death via upregulation of SLC22A16 , 2018, Cell Death & Disease.
[46] M. Keidar,et al. Paclitaxel-Loaded Core-Shell Magnetic Nanoparticles and Cold Atmospheric Plasma Inhibit Non-Small Cell Lung Cancer Growth. , 2018, ACS applied materials & interfaces.
[47] Wenbin Lin,et al. Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy , 2018, Nature Communications.
[48] Euisik Yoon,et al. Scalable Multiplexed Drug-Combination Screening Platforms Using 3D Microtumor Model for Precision Medicine. , 2018, Small.
[49] K. Weltmann,et al. Cytochrome C oxidase Inhibition and Cold Plasma-derived Oxidants Synergize in Melanoma Cell Death Induction , 2018, Scientific Reports.
[50] T. von Woedtke,et al. The kINPen—a review on physics and chemistry of the atmospheric pressure plasma jet and its applications , 2018 .
[51] Chao-Yu Chen,et al. Synergistic effects of plasma-activated medium and chemotherapeutic drugs in cancer treatment , 2018 .
[52] K. Schröder,et al. Redox control in cancer development and progression. , 2018, Molecular aspects of medicine.
[53] E. Choi,et al. Clinical experience with cold plasma in the treatment of locally advanced head and neck cancer , 2018 .
[54] K. Weltmann,et al. Plasma, cancer, immunity , 2018, Clinical Plasma Medicine.
[55] D. Schadendorf,et al. Actinic keratoses treated with cold atmospheric plasma , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.
[56] Fernanda Borges,et al. Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances. , 2017, Journal of medicinal chemistry.
[57] K. Weltmann,et al. Role of Ambient Gas Composition on Cold Physical Plasma-Elicited Cell Signaling in Keratinocytes. , 2017, Biophysical journal.
[58] Jae Hoon Jeong,et al. miR-24-mediated knockdown of H2AX damages mitochondria and the insulin signaling pathway , 2017, Experimental &Molecular Medicine.
[59] Jeffrey A. Engelman,et al. Prospects for combining targeted and conventional cancer therapy with immunotherapy , 2017, Nature Reviews Cancer.
[60] Vandana Miller,et al. Successful treatment of actinic keratoses using nonthermal atmospheric pressure plasma: A case series , 2017, Journal of the American Academy of Dermatology.
[61] A. di Pietro,et al. New, highly potent and non-toxic, chromone inhibitors of the human breast cancer resistance protein ABCG2. , 2016, European journal of medicinal chemistry.
[62] T. von Woedtke,et al. Visible tumor surface response to physical plasma and apoptotic cell kill in head and neck cancer. , 2016, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[63] Yonghong Shi,et al. High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells. , 2016, Blood.
[64] Joel N. Meyer,et al. Distinctive adaptive response to repeated exposure to hydrogen peroxide associated with upregulation of DNA repair genes and cell cycle arrest , 2016, Redox biology.
[65] J. Ruano,et al. Clinical and Biological Principles of Cold Atmospheric Plasma Application in Skin Cancer , 2016, Advances in Therapy.
[66] P. Cullen,et al. Non-thermal atmospheric plasma induces ROS-independent cell death in U373MG glioma cells and augments the cytotoxicity of temozolomide , 2016, British Journal of Cancer.
[67] K. Weltmann,et al. Synergistic Inhibition of Tumor Cell Proliferation by Cold Plasma and Gemcitabine , 2015 .
[68] D. V. Hoff,et al. Head and neck cancer treatment and physical plasma , 2015 .
[69] T. von Woedtke,et al. Non-thermal Plasma Activates Human Keratinocytes by Stimulation of Antioxidant and Phase II Pathways , 2015, The Journal of Biological Chemistry.
[70] A. di Pietro,et al. MBL-II-141, a chromone derivative, enhances irinotecan (CPT-11) anticancer efficiency in ABCG2-positive xenografts , 2014, Oncotarget.
[71] F. Mechta-Grigoriou,et al. The role of reactive oxygen species and metabolism on cancer cells and their microenvironment. , 2014, Seminars in cancer biology.
[72] K. Weltmann,et al. Reactive species output of a plasma jet with a shielding gas device—combination of FTIR absorption spectroscopy and gas phase modelling , 2014 .
[73] A. Bogaerts,et al. Kinetic modelling for an atmospheric pressure argon plasma jet in humid air , 2013 .
[74] J. Zimmermann,et al. Restoration of Sensitivity in Chemo — Resistant Glioma Cells by Cold Atmospheric Plasma , 2013, PloS one.
[75] A. le Pape,et al. Effects of a Non Thermal Plasma Treatment Alone or in Combination with Gemcitabine in a MIA PaCa2-luc Orthotopic Pancreatic Carcinoma Model , 2012, PloS one.
[76] David B. Graves,et al. The emerging role of reactive oxygen and nitrogen species in redox biology and some implications for plasma applications to medicine and biology , 2012 .
[77] J. Leonardi-Bee,et al. A systematic review of worldwide incidence of nonmelanoma skin cancer , 2012, The British journal of dermatology.
[78] Nikhil Wagle,et al. Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[79] R. Amato,et al. Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study , 2010, Clinical Cancer Research.
[80] I. Afanas’ev. Signaling by reactive oxygen and nitrogen species in skin diseases. , 2010, Current drug metabolism.
[81] A. Lupu,et al. Tumoral and Normal Cells Treatment With High-Voltage Pulsed Cold Atmospheric Plasma Jets , 2010, IEEE Transactions on Plasma Science.
[82] Jun Fang,et al. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. , 2009, Advanced drug delivery reviews.
[83] C. Divino,et al. The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. , 2009, Cancer research.
[84] E. Calabrese. Hormesis and medicine. , 2008, British journal of clinical pharmacology.
[85] Z. Darżynkiewicz,et al. Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[86] S. Mizutani,et al. Phosphorylation of histone H2AX at M phase in human cells without DNA damage response. , 2005, Biochemical and biophysical research communications.
[87] Anke Schmidt,et al. Safety Aspects of Non-Thermal Plasmas , 2018 .
[88] T. von Woedtke,et al. Plasma medicine—current state of research and medical application , 2016 .